Search
for
Sort by
Research 241–270 of 730
- The brief overview, antivirus and anti-SARS-CoV-2 activity, quantitative methods, and pharmacokinetics of cepharanthine: a potential small-molecule drug against COVID-19
- LB1059 Neuromediators associated with neurogenic skin inflammation promote M2 differentiation of macrophages in human skin ex vivo
- The antiviral activity of a small molecule drug targeting the NSP1-ribosome complex against Omicron, especially in elderly patients
- Prolonged use of finasteride-induced gonadal sex steroids alterations, DNA damage and menstrual bleeding in women
- Ontogenetic Transition in Fetal Wound Transforming Growth Factor-β Regulation Correlates with Collagen Organization
- SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction
- Interleukin-6 from Adipose-Derived Stem Cells Promotes Tissue Repair by the Increase of Cell Proliferation and Hair Follicles in Ischemia/Reperfusion-Treated Skin Flaps
- ACKR2 limits skin fibrosis and hair loss through IFN‐β
- Sorafenib stimulates human skin type mast cell degranulation and maturation
- Identification of an osteopontin-derived peptide that binds neuropilin-1 and activates vascular repair responses and angiogenesis
- Repurposing existing drugs for the treatment ofCOVID-19/SARS-CoV-2: A review of pharmacological effects and mechanism of action
- Mucosal TLR5 activation controls healthspan and longevity
- DKK1-targeting cholesterol-modified siRNA implication in hair growth regulation
- CXCL12 inhibits hair growth through CXCR4
- Niacinamide Down-Regulates the Expression of DKK-1 and Protects Cells from Oxidative Stress in Cultured Human Dermal Papilla Cells
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Thymic stromal lymphopoietin controls hair growth
- Increased risk of chronic fatigue and hair loss following COVID-19 in individuals with hypohidrotic ectodermal dysplasia
- Hair Loss Induced by Tumor Necrosis Factor Alpha Inhibitors
- Gene therapy for alopecia in type II rickets model rats using vitamin D receptor-expressing adenovirus vector
- An Update on the Roles of the Complement System in Autoimmune Diseases and the Therapeutic Possibilities of Anti-Complement Agents
- Pathophysiological mechanisms of hair follicle regeneration and potential therapeutic strategies
- Telitacicept for systemic lupus erythematosus with post‑surgical papillary thyroid carcinoma: A case report
- Hyaluronate Fragments Reverse Skin Atrophy by a CD44-Dependent Mechanism
- SARS-CoV-2 Spike Protein S1-Mediated Endothelial Injury and Pro-Inflammatory State Is Amplified by Dihydrotestosterone and Prevented by Mineralocorticoid Antagonism
- The immune response to COVID‐19: Does sex matter?
- The X Factor in Immunity: Sex Differences Shaped by the X Chromosome
- Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound?
- The Influence of Allium cepa Extracts on Promotion of Hair Growth
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition